Research location

Barcelona

Catalonia, Spain

Published trials374

Site observations516

Linked trials published374

Page1 / 8

Research activity in Barcelona

Catalonia, Spain

CureCurrent currently publishes aggregate city-level research activity for this location: 374 trials and 516 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Barcelona

374 linked trials · page 1 of 8

Personalized Brain Health Service and Dementia PreventionNCT07698431 · 2026-09-15 · 1 site observation

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS MutationsNCT07629960 · 2026-06-04 · 2 site observations

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)NCT07318597 · 2026-05-06 · 1 site observation

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)NCT07513376 · 2026-05-04 · 1 site observation

A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.NCT07593820 · 2026-04-29 · 2 site observations

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)NCT07365332 · 2026-04-23 · 1 site observation

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)NCT07531095 · 2026-04-21 · 1 site observation

Concomitant Use of Radiotherapy and Integrated Exercise - Lung CancerNCT07489391 · 2026-04-01 · 1 site observation

Evaluation of a Multicomponent Early Intervention for Childhood Obesity Prevention in Vulnerable FamiliesNCT07529704 · 2026-03-02 · 1 site observation

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease DementiaNCT07284472 · 2026-02-02 · 1 site observation

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down SyndromeNCT07234695 · 2025-12-22 · 1 site observation

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerNCT07007559 · 2025-12-10 · 1 site observation

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerNCT07213674 · 2025-11-28 · 2 site observations

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)NCT07190248 · 2025-10-08 · 1 site observation

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLCNCT07246863 · 2025-10-07 · 1 site observation

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate CancerNCT07005154 · 2025-08-19 · 1 site observation

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLCNCT07098988 · 2025-08-01 · 2 site observations

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid TumorsNCT07094113 · 2025-07-31 · 1 site observation

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsNCT07094204 · 2025-07-25 · 1 site observation

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 2 site observations

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)NCT07033494 · 2025-07-16 · 1 site observation

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesNCT06570798 · 2025-07-16 · 2 site observations

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 2 site observations

Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic SclerosisNCT07236970 · 2025-05-30 · 1 site observation

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)NCT06780098 · 2025-05-28 · 1 site observation

Augmentation of EMDR With tDCS in the Treatment of FibromyalgiaNCT04084795 · 2025-01-21 · 1 site observation

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.NCT06724159 · 2024-12-13 · 4 site observations

Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsNCT06625775 · 2024-10-29 · 1 site observation

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)NCT06649110 · 2024-10-24 · 1 site observation

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)NCT06598306 · 2024-10-07 · 1 site observation

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCNCT06216301 · 2024-07-31 · 1 site observation

Tapping Test and the Archimedean Spiral for the Differential Diagnosis of Tremor. Machine Learning ApproachNCT06378619 · 2024-07-15 · 1 site observation

Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.NCT07717268 · 2024-05-16 · 1 site observation

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.NCT05939414 · 2024-03-12 · 1 site observation

Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for PsychosisNCT07091344 · 2024-03-01 · 1 site observation

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)NCT06136650 · 2023-12-18 · 1 site observation

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)NCT05920356 · 2023-11-16 · 4 site observations

Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)NCT05898399 · 2023-06-30 · 1 site observation

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)NCT05714085 · 2023-05-31 · 1 site observation

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsNCT05732831 · 2023-05-26 · 1 site observation

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsNCT05592626 · 2023-01-04 · 1 site observation

Long-term Safety and Efficacy of GBG Study ParticipantsNCT05739591 · 2022-10-12 · 3 site observations

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast CancerNCT05216432 · 2021-12-08 · 1 site observation

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)NCT07218029 · 2021-05-12 · 1 site observation

A Study of Sigvotatug Vedotin in Advanced Solid TumorsNCT04389632 · 2020-06-08 · 1 site observation

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerNCT04221542 · 2020-03-04 · 2 site observations

Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.NCT03851523 · 2018-02-12 · 1 site observation

Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative DiseasesNCT04706234 · 2017-09-01 · 1 site observation

International Registry for Men With Advanced Prostate Cancer (IRONMAN)NCT03151629 · 2017-07-21 · 1 site observation

Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project ParticipantsNCT02685969 · 2017-03-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.